Pages that link to "Q38003690"
Jump to navigation
Jump to search
The following pages link to The impact of proteomics in the understanding of the molecular basis of Paclitaxel-resistance in ovarian tumors. (Q38003690):
Displaying 7 items.
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer (Q35587385) (← links)
- Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma (Q38542060) (← links)
- Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling (Q38913984) (← links)
- Platelet protein biomarker panel for ovarian cancer diagnosis (Q48222655) (← links)
- Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles (Q49387560) (← links)
- Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p (Q58581353) (← links)
- G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future (Q91603671) (← links)